top of page
Latest News
Search
A New Single-Tablet Option for HIV's "Forgotten Population" Could Change Lives. Will Policy Let It?
New Phase 3 data show a single-tablet regimen of bictegravir/lenacapavir could finally bring one-pill simplicity to long-term HIV survivors locked into complex regimens by decades of drug resistance. The science is closing the treatment gap. Will our policy systems do the same?
Travis Roppolo
Mar 309 min read
Are Cancer Risks Higher for People Living with HIV/AIDS
Research on elevated cancer risks in PLWHA and importance of early detection.
Riley Johnson
Mar 3, 20243 min read
We Need Your Support Today!
bottom of page